US pauses distribution of Lilly mAb combo to Massachusetts due to Covid-19 variant

Now that the CDC has found that the Covid-19 variant originally identified in Brazil is circulating with a frequency exceeding 10% in Massachusetts, the US has halted shipments of Eli Lilly’s monoclonal antibody combo treatment because it’s not active against this variant.